PTPN11 and acute myeloid leukemia: Transplantation of HSCs co-expressing PTPN11 E76K and MLL-AF9 fusion oncogenes induced a lower survival rate and more severe AML phenotype in vivo, such as splenomegaly (Chen L. et al., 2015).